NEBGH Members only, Webinar

NEBGH Medical Director’s Bi-Weekly Monday COVID-19 Update

This is a NEBGH Members only event. If you are interested in attending and not a member, please contact Elizabeth at emerrill@nebgh.org

Mondays with Dr. Mark: The Latest on COVID-19

Here’s a fast and easy way to understand what the newest info on the pandemic means for you and your employees.

From infection risk and safety measures to the outlook for vaccines and treatments, NEBGH’s medical director breaks it all down for you.

Every other Monday at 1 PM – it’s appointment viewing!

Panelists

Featured Speaker:

Dr. Mark Cunningham-Hill

Medical Director

NEBGH

Dr. Cunningham-Hill is an employee health expert known for his ability to create, identify and implement high-quality workplace health programs including prevention and screening, chronic illness interventions, and mental health and wellbeing initiatives. His broad occupational medicine and public health experience encompasses addressing chronic diseases impacting employers, employees and communities within the context of social, cultural and racial determinants of health.

Mark has served as the Medical Director for Northeast Business Group on Health since early 2018. Until 2017, he served as Senior Director, Global Solutions Center and Head of Occupational Medicine at Johnson & Johnson, Inc . At J&J, Mark led a team of experts covering occupational medicine, health and wellness, personal energy management, EAP and mental wellbeing, and work-life effectiveness, and supported regional operational groups delivering health services to 135,000 employees in 120 companies. Prior to seven years at J&J, Mark spent 17 years at GlaxoSmithKline in both London and Philadelphia, including as Head of Global Operations, Employee Health Management.

Mark received his MB ChB, Bachelor of Medicine and Bachelor of Surgery at Manchester University in the UK. He is a Fellow of both the American College of Occupational & Environmental Medicine, and the Faculty of Occupational Medicine, London.